Search Ontology:
ChEBI
N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-D-galactosamine
- Term ID
- CHEBI:146820
- Synonyms
-
- (2R,4S,5R,6R)-5-acetamido-2-[[(2R,3R,4R,5R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
- 2-acetamido-6-O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-2-deoxy-D-galactopyranose
- 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid-(2->6)-2-acetamido-2-deoxy-D-galacto-hexopyranose
- alpha-Neu5Ac-(2->6)-GalpNAc
- NeuAc(a2-6)GalNAc
- WURCS=2.0/2,2,1/[a2112h-1x_1-5_2*NCC/3=O][Aad21122h-2a_2-6_5*NCC/3=O]/1-2/a6-b2
- Definition
- An amino disaccharide composed of N-acetylneuraminic acid and 2-(acetylamino)-2-deoxy-D-galactopyranose residues joined by an (alpha-2->6) glycosidic bond.
- References
-
- GlyGen:G08371CD
- GlyTouCan:G08371CD
- KEGG:G00455
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has subtype
-
Phenotype
Phenotype resulting from N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-D-galactosamine
Phenotype where environments contain N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-D-galactosamine
Phenotype modified by environments containing N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-D-galactosamine
Human Disease Model